Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
Background: Apolipoprotein C1 (APOC1) has been proved to play a critical role in gastric, breast, lung, and pancreatic cancer. However, the relationship between APOC1 and urinary tumors remains unclear. This study aimed to assess the diagnostic and prognostic value of APOC1 in urinary tumors.Methods...
Main Authors: | Yankang Cui, Chenkui Miao, Chao Hou, Zengjun Wang, Bianjiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01436/full |
Similar Items
-
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01) -
Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma
by: Adam Kowalewski, et al.
Published: (2020-11-01) -
Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma
by: Xian Chang, et al.
Published: (2021-01-01) -
Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
by: Zhulin Wu, et al.
Published: (2020-11-01) -
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma
by: Kaili Chang, et al.
Published: (2021-04-01)